Carbapenem-resistant Enterobacteriaceae: biology, epidemiology, and management
- PMID: 25195939
- DOI: 10.1111/nyas.12537
Carbapenem-resistant Enterobacteriaceae: biology, epidemiology, and management
Abstract
Introduced in the 1980s, carbapenem antibiotics have served as the last line of defense against multidrug-resistant Gram-negative organisms. Over the last decade, carbapenem-resistant Enterobacteriaceae (CRE) have emerged as a significant public health threat. This review summarizes the molecular genetics, natural history, and epidemiology of CRE and discusses approaches to prevention and treatment.
Keywords: antimicrobial resistance; carbapenem-resistant Enterobacteriaceae; carbapenemases; infection control; molecular genetics; treatment.
© 2014 New York Academy of Sciences.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
